(Q37800481)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Health-state utility values in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sue Ward

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

John Brazier

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Pharmacoeconomics & Outcomes Research

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

553-566

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

The estimation of a preference-based measure of health from the SF-36.

15 February 2020

cites work

1 reference

Multi-attribute health status classification systems. Health Utilities Index

21 January 2018

1 reference

Estimating a preference-based single index from the Overactive Bladder Questionnaire.

21 January 2018

1 reference

A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures

21 January 2018

1 reference

Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis

21 January 2018

1 reference

Costs and net health effects of contraceptive methods

21 January 2018

1 reference

Health-state utilities in liver disease: a systematic review.

21 January 2018

1 reference

A review and meta-analysis of prostate cancer utilities.

21 January 2018

1 reference

A meta-analysis of utility estimates for HIV/AIDS.

21 January 2018

1 reference

A meta-analysis of quality-of-life estimates for stroke

21 January 2018

1 reference

Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis

21 January 2018

1 reference

Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff.

21 January 2018

1 reference

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

21 January 2018

1 reference

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

21 January 2018

1 reference

Quality of life valuations of mammography screening

21 January 2018

1 reference

Measuring women's preferences for breast cancer treatments and BRCA1/BRCA2 testing.

21 January 2018

1 reference

A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation

21 January 2018

1 reference

Tamoxifen for breast cancer prevention: a framework for clinical decisions.

21 January 2018

1 reference

The impact of the perception of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life

21 January 2018

1 reference

Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment

21 January 2018

1 reference

21 January 2018

1 reference

The feasibility and responsiveness of the health utilities index in patients with early-stage breast cancer: a prospective longitudinal study.

21 January 2018

1 reference

Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen alone or in combination) trial

21 January 2018

1 reference

Can differences in breast cancer utilities explain disparities in breast cancer care?

21 January 2018

1 reference

Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis

21 January 2018

1 reference

Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials

21 January 2018

1 reference

Health state utilities for metastatic breast cancer

21 January 2018

1 reference

Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost.

21 January 2018

1 reference

Quality-of-life valuations of advanced breast cancer by New Zealand women.

21 January 2018

1 reference

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer

21 January 2018

1 reference

Cost effectiveness of treatment options in advanced breast cancer in the UK.

21 January 2018

1 reference

Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate.

21 January 2018

1 reference

Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer

21 January 2018

1 reference

Impact of nausea/vomiting on quality of life as a visual analogue scale-derived utility score

21 January 2018

1 reference

A cost utility analysis of mammography screening in Australia.

21 January 2018

1 reference

21 January 2018

1 reference

Are health states 'timeless'? A case study of an acute condition: post-chemotherapy nausea and vomiting.

21 January 2018

1 reference

A longitudinal study of health related quality of life and utility measures in patients with advanced breast cancer.

21 January 2018

1 reference

Comparison of time-tradeoff utilities and rating scale values of cancer patients and their relatives: evidence for a possible plateau relationship.

21 January 2018

1 reference

Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients.

21 January 2018

1 reference

Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data

21 January 2018

1 reference

Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general.

21 January 2018

1 reference

A systematic review of health state utility values for osteoporosis-related conditions

21 January 2018

1 reference

An updated systematic review of Health State Utility Values for osteoporosis related conditions

21 January 2018

1 reference

Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy.

21 January 2018

1 reference

The role of a pre-scored multi-attribute health classification measure in validating condition-specific health state descriptions.

21 January 2018

1 reference

Valuing temporary and chronic health states associated with breast screening.

21 January 2018

1 reference

Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nationwide, population-based assessment

21 January 2018

1 reference

Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods

21 January 2018

1 reference

Impact of screening for breast cancer in high-risk women on health-related quality of life

21 January 2018

1 reference

The association between symptom burdens and utility in Chinese cancer patients.

21 January 2018

1 reference

A preference-based index for the SF-12.

21 January 2018

1 reference

Burden of illness in cancer survivors: findings from a population-based national sample.

21 January 2018

1 reference

Valuing health States for use in cost-effectiveness analysis

21 January 2018

1 reference

A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer

21 January 2018

1 reference

A new decision model for cost-utility comparisons of chemotherapy in recurrent metastatic breast cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.10.65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20950071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference